Skip to main content
Erschienen in: African Journal of Urology 1/2020

Open Access 01.12.2020 | Original Research

Modified R.E.N.A.L nephrometry score for predicting the outcome following partial nephrectomy

verfasst von: Mohammed Salah, Mohammed S. ElSheemy, Waleed Ghoneima, Mahmoud Abd El Hamid, Ayman Kassem, Ahmed Abdallah Ashmawy, Ismail R. Saad, Ashraf A. Mosharafa, Hosni Khairy Salem, Hesham Badawy, Ahmed Salem

Erschienen in: African Journal of Urology | Ausgabe 1/2020

Abstract

Background

It was difficult to compare the outcome of partial nephrectomy among different studies due to the absence of standardized description of different renal masses. This problem led to the development of nephrometry scoring systems. R.E.N.A.L. is among the commonest nephrometry scoring systems; however, some studies failed to find any relation between R.E.N.A.L. with perioperative outcome. We evaluated our designed newly modified nephrometry score in prediction of outcome following partial nephrectomy and compared its predictability versus original R.E.N.A.L.

Methods

Fifty-one patients with cT1-2N0M0 renal masses amenable for partial nephrectomy were included prospectively. Different perioperative outcome variables were compared according to complexity level in R.E.N.A.L. and the newly modified nephrometry score.

Results

Clinical staging was T1a (21.6%), T1b (49%), T2a (25.5%), T2b (3.9%). Median R.E.N.A.L. was 9 (4–12). Hilar position and intrarenal pelvis were detected in 19.6% and 68.6%. Low, moderate and high complexity masses were found in 21.6%, 39.2% and 39.2%. Complications and rate of conversion to radical nephrectomy were 17 (33.3%) and 4 (7.8%). The only significantly affected variable (p = 0.039) by R.E.N.A.L. was rate of secondary intervention, but it was higher in low than in high complexity level. In the newly modified nephrometry score, complications (p = 0.037) and rate of positive surgical margin (p = 0.049) were significantly higher with increased complexity level. Although other variables (pelvi-calyceal system entry, operative time, blood loss, hemoglobin loss, blood transfusion and conversion to radical nephrectomy) did not show statistically significant difference according to both scores, they were better associated with the complexity level in the newly modified nephrometry score with their remarkable increase in the high when compared to the low complexity level.

Conclusions

The newly modified nephrometry score was associated with better prediction of outcome of partial nephrectomy when compared to R.E.N.A.L.
Hinweise

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Abkürzungen
eGFR
Estimated glomerular filtration rate
MDRM
Modification of diet in renal disease equation
MNS
Newly modified nephrometry score
NS
Nephrometry scoring systems
PCS
Pelvi-calyceal system entry
PN
Partial nephrectomy
RPS
Renal Pelvic Score
RN
Radical nephrectomy
WIT
Warm ischemia time

1 Background

The rate of detection of renal masses has been increased due to improved imaging techniques [1]. This raised the need for treatment modalities other than radical nephrectomy (RN) to preserve renal function as possible including partial nephrectomy (PN) [15]. It is indicated in localized renal masses (cT1) [6]. Furthermore, PN can safely be performed in cT2 renal masses with acceptable technical and oncological outcomes and with maximal parenchymal preservation, especially in solitary kidney or bilateral tumors [2, 7, 8]. However, PN is associated with increased risk of overall complications [2, 4, 9].
Many studies were conducted to evaluate the outcome of PN, but it was difficult to compare them as there were no standardized criteria to unify the description of different renal masses. This problem led to the development of nephrometry scoring systems (NS) to unify as possible the description of the renal masses. There are many scoring systems including the PAUDA [10], the centrality index (C-index) method [11] and the R.E.N.A.L. NS [12]. Another problem in the management of renal masses using PN was the bias in decision which was based mainly on surgeon preferences and experience without standard criteria [12]. Consequently, these NS were tried to predict the outcome of PN [13]. This could help in decision making by proper selection of the surgical procedure.
R.E.N.A.L. is one of these nephrometry scoring systems that was thoroughly evaluated. However, some studies failed to find any relation between R.E.N.A.L. with operative parameters or postoperative outcome [1318]. Thus, the need for continuous improvement in these NS is obvious for better prediction of the outcome and proper selection of the surgical technique.
Our aim was to evaluate our designed newly modified nephrometry score (MNS) in prediction of the outcome following PN for renal masses and to compare its predictability versus original R.E.N.A.L.

2 Methods

2.1 Study design and inclusion criteria

This was a prospective study for adult patients (≥ 18 years old) who presented consecutively between September 2014 and December 2016 with cT1-2N0M0 renal masses amenable for PN. Indications for PN were patients with solitary kidney, bilateral renal masses, chronic kidney disease or risk of future renal impairment as in cases of hypertension or diabetes, to preserve renal function. Additionally, patients with small renal masses < 4 cm were included even with normal contralateral kidney. We excluded patients with previous renal or abdominal surgeries. The study was approved by institutional review board, and written informed consent was obtained from all patients.

2.2 Clinical assessment

Routine preoperative investigations were performed including CBC, coagulation profile and serum creatinine. Estimated glomerular filtration rate (eGFR) was calculated using the Modification of Diet in Renal Disease (MDRM) equation [19]. Contrast-enhanced cross-sectional imaging of chest, abdomen and pelvis (CT or MRI) for each patient was assessed by two uro-oncologists familiar with the Renal Pelvic Score (RPS) [20] and the R.E.N.A.L [12]. If the two members disagreed in the scoring, a third opinion was obtained.

2.3 Surgical management and postoperative care

After positioning of the patient in the lateral decubitus position, all patients underwent open PN with a flank incision performed with excision of the 11th rib to gain access to the targeted kidney. Trans-gerotal approach was adopted in all cases, where dissection of the peri-renal fat was done except the area surrounding the mass. Site of the mass was identified intraoperatively by either direct visualization of the mass or ultrasound guidance, especially if the mass was totally endophytic. After intraoperative mass assessment, we decided to proceed with either warm ischemia or no ischemia. The incision line for the mass, outside its capsule and surrounding a rim of normal parenchyma, was outlined then deepened using a combination of blunt and sharp dissection, then the mass was removed with its surrounding fat. A sample from the deepest point of the bed was obtained for histopathological examination. Bleeding vessels and injuries to pelvi-calyceal system were repaired. Reconstruction of the renal bed was done by placement of hemostatic materials in the form of an oxidized cellulose polymer and/or oxidized regenerated cellulose. Parenchymal closure with the covering capsule was done using interrupted absorbable 2/0 sutures with the aid of oxidized cellulose polymer to support the sutures. We didn’t routinely insert a ureteric stent. Urethral catheter was removed on (day 1) while the drain was left for an average of 3 days then removed with discharge of the patient.
Follow-up visits were at 1, 4 and 12 week then at 6 and 12 months postoperatively. In each visit, evaluation was done by serum creatinine, eGFR, urine analysis and US. Additionally, CT or MRI was performed at 6 and 12 months.

2.4 Data collection

Different outcome parameters were reported including warm ischemia time (WIT), operative time, estimated blood loss, blood transfusion, renal vascular injury, ureteric or renal pelvis injury, pelvi-calyceal system (PCS) entry, conversion to RN, urinary leakage, length of hospital stay, postoperative renal function and pathology findings.

2.5 Newly modified nephrometry score (MNS)

We compared different outcome parameters according to R.E.N.A.L. and RPS. We modified R.E.N.A.L. with incorporation of new items in the score including hilar position of the mass as a numerical score not only a descriptive character (scored 0 or 5) and RPS (scored 1 or 3 according to the percentage of renal pelvis area contained inside the volume of the renal parenchyma whether less or more than 50%; respectively). Furthermore, we changed the score points given to some items of the original R.E.N.A.L. according to our point of view regarding their importance in describing the complexity of the mass. We kept the score of the radius “R” and relation to polar lines “L” as 1, 2 or 3, but we changed the score of the nearness to PCS and sinus “N” to 1, 2 or 4 and the score of the endophytic nature of the mass “E” to 1, 2 or 5. Accordingly, the new score is ranging from 5 to 23. It is classified into mild complexity (5–9), moderate complexity (10–14) or high complexity (15–23). A renal mass can be described using the MNS as (R + E + N + apx + L + H + RPS). The newly modified nephrometry score was used to compare the different outcome parameters to evaluate its predictability and whether it was better or not than R.E.N.A.L.

2.6 Statistical analysis

The Statistical Package of Social Science (SPSS) Software program, version 20, was used for statistical analysis. Nominal values were compared using Chi-square (χ2) test or Fisher-exact test as appropriate. For comparing numerical values of the three complexity groups, the one way ANOVA (with Post Hoc analysis) or Kruskal–Wallis test were used. p values < 0.05 were considered statistically significant.

3 Results

3.1 Demographic and perioperative data

Fifty-one consecutive patients with renal masses were included. The baseline characteristics are shown in Table 1. Perioperative data are presented in Table 2. Perioperative complications were detected in 17 (33.3%) patients. Injury to the renal artery was reported in 2 patients. Exploration of the renal artery revealed an intimal crack in the first patient; which was repaired, and a blood clot in the second patient; which was dislodged by Fogarty catheter. Postoperative hematuria that failed to respond to intravenous fluid and anti-bleeding measures were detected in 2 patients on day 5 and day 7, respectively. Diagnostic angiography was done and showed AV fistula formation which was controlled by injection of histoacryl. There were 6 cases of postoperative urine leakage. This was associated with perinephric collection in 2 patients. Four cases required double-J stent insertion, while the other 2 cases were successfully managed conservatively by urethral catheter insertion or extending the duration of the already inserted catheter. No pre- or intraoperative stenting was done except for 1 patient who had ureteric injury during dissection of a lower polar mass. Conversion to RN was mandated in 4 (7.8%) patients due to inadequate residual renal tissue after PN (1), severe injury to PCS after excision of the mass with impossible repair (1), failure to localize the site of a completely endophytic renal mass close to renal hilum even after the use of ultrasound (1) and involvement of the hilar vessels by the renal mass in the 4th patient.
Table 1
Preoperative demographic data of the patients and characteristics of the renal masses
 
51 patients
Age (years)
50.19 ± 13.25 (20–80)
Sex: male/female
29 (56.9%)/22 (43.1%)
Medical disease (DM, HTN, IHD and/or stroke)
25 (49%)
CKD (ml/min/1.73 m2): > 90/60–89/30–59
17 (33.3%)/26 (51%)/8 (15.7%)
Solitary kidney
2 (3.9%)
Side: right/left
30 (58.8%)/21 (41.2%)
Clinical T
 
 1a
11 (21.6%)
 1b
25 (49%)
 2a
13 (25.5%)
 2b
2 (3.9%)
Position: anterior/posterior/“X”
15 (29.4%)/28 (54.9%)/8 (15.7%)
Hilar position
10 (19.6%)
Renal Pelvic Score: extrarenal/intrarenal
16 (31.4%)/35 (68.6%)
Complexity: low/moderate/high
11 (21.6%)/20 (39.2%)/20 (39.2%)
Modified complexity: low/moderate/high
15 (29.4%)/20 (39.2%)/16 (31.4%)
Indications for PN
 
 CKD
3 (5.9%)
 Medical disease (HTN + DM)
14 (27.4%)
 CKD + medical disease
4 (7.8%)
 SRM/peripheral mass
24 (47.0%)
 AML with bleeding
3 (5.9%)
 Solitary
1 (2%)
 Bilateral masses
2 (3.9)
BMI (kg/m2)
29.8 ± 5.2 (21–42)
ASA Score
1 (1–2)
Pre-Op eGFR (ml/min/1.73 m2)
84.6 ± 24.5 (40–141)
Pre-Op Hb (gm/dl)
13.2 ± 1.7 (9.1–16.4)
R.E.N.A.L.
9 (4–12)
MNS
12 (6–22)
Values were presented as mean ± SD (range), median (range) or number of patients (%) as appropriate
ASA American society of anesthesiology, BMI body mass index, CKD chronic kidney disease, DM diabetes mellitus, eGFR estimated glomerular filtration rate, Hb hemoglobin, HTN hypertension, IHD ischemic heart disease, MNS newly modified nephrometry score, Pre-Op preoperative, SRM small renal mass
Table 2
Perioperative data, complications and follow-up
Operative time (h)
3 ± 0.7 (1.75–5)
Ischemia type: warm ischemia/zero ischemia
40 (78.4%)/11 (21.6%)
WIT (min)
15.1 ± 9.8 (0–40)
PCS entry
26 (51%)
Blood transfusion
9 (17.6%)
Blood loss (ml)
250 (50–1500)
Conversion to radical nephrectomy
4 (7.8%)
Post-Op Hb (gm/dl)
11.8 ± 1.8 (7.1–15.8)
Hb loss (gm/dl)
1 (0.10–5.3)
Perioperative complicationsa
17 (33.3%)
 Grade I
 
  Fever
7 (13.7%)
 Grade II
 
  Blood transfusion
9 (17.6%)
  Leakage (conservative)
1 (2%)
  Perinephric collection and leak (conservative)
1 (2%)
 Grade III
 
  Leak (endoscopic stenting)
3 (5.88%)
  Perinephric collection and leak (endoscopic stenting)
1 (2%)
  AVF (Embolization)
2 (3.9%)
  Ureteric injury
2 (3.9%)
  Renal artery thrombosis/intimal injury
2 (3.9%)
Drain removal/length of hospital stay (days)
5 (3–28)/5 (3–29)
Pathological T
 
 Benign
11 (21.6%)
 1a/1b
9 (17.6%)/17 (33.3%)
 2a/2b
8 (15.7%)/5 (5.9%)
 3a
1 (2%)
Histologic type
 
  Clear cell
26 (51%)
  Papillary/chromophobe/esinophilic
6 (11.8%)/7 (13.7%)/1 (2%)
  Benign lesions: (AML/oncocytoma)
11 (21.56%)
Fuhrman grade: I/II/III
18 (35%)/21 (41.2%)/1 (2%)
Positive surgical margin
3 (5.9%)
Post-Op eGFR 3 mo (ml/min/1.73 m2)
77.7 ± 22.1 (21.8–130)
Values are presented as mean ± SD (range), median (range) or number of patients (%) as appropriate
AML angiomyolipoma, AVF arteriovenous fistula, eGFR estimated glomerular filtration rate, Hb hemoglobin, PCS pelvi-calyceal system, Post-Op postoperative, WIT warm ischemia time
aAccording to Clavien-Dindo classification system
Six patients developed postoperative renal function deterioration. Only one of these six patients had normal preoperative renal functions. The preoperative eGFR was (91 ml/min). The creatinine raised from 1 to 3.5 mg/dl immediately postoperatively. On follow-up after 3 months, eGFR improved to 88 ml/min; which was very close to preoperative reading. No patient developed recurrence after a 1 year follow-up.

3.2 Pathological data

The clear cell type was the most dominant pathological finding (26 cases) (Table 2). The cases of positive surgical margins (5.9%) were followed up every 3 months with cross-sectional imaging.

3.3 Effect of complexity on outcome according to R.E.N.A.L. and MNS

Different perioperative factors were compared according to complexity level in R.E.N.A.L. (Table 3) and MNS (Table 4). There was no statistically significant difference between the complexity groups in the preoperative characteristics in both scores. In R.E.N.A.L., the only detected variable that was affected significantly (p = 0.039) by the complexity level was the need for secondary intervention. The hilar position (H) and RPS showed statistically significant difference only according to MNS as they were not included in the original R.E.N.A.L. In MNS, the complication rate was significantly higher with increase in the complexity level (p = 0.037). Furthermore, the rate of complications was nearly doubled while moving from a low complexity level to a higher level (13.3% vs 30% vs 56.3%) which was completely different from the original R.E.N.A.L. The rate of positive surgical margin showed statistically significant difference according to MNS (p = 0.049) and was found only in the highest complexity level while it showed no significant difference according to the original R.E.N.A.L in which it was found in both moderate and high complexity levels. Although secondary intervention showed statistically significant difference in the original score (p = 0.039), it was higher in the low complexity level (18.2%) than in the high complexity level (5%). The relation of the rate of secondary intervention became better associated with the complexity level in the MNS although the significant difference was abolished (p = 0.757). Although the rate of PCS entry did not show statistically significant difference according to complexity level in both scores, it was more associated with the complexity level in MNS with nearly doubling when comparing the low and high levels (33.3% vs 62.5%, respectively) while in R.E.N.A.L, the rate of PCS entry was higher in the low than the moderate complexity. This more association with the level of complexity, in the absence of significant difference, was also observed in MNS when compared with the original score in many other perioperative outcome variables including operative time, WIT, blood loss, hemoglobin loss, blood transfusion, ureteric injury and conversion to RN.
Table 3
Renal mass complexity according to R.E.N.A.L. NS in relation to outcome parameters
 
Complexity level according to R.E.N.A.L.
p
Low (4–6)
11 patients
Moderate (7–9)
20 patients
High (10–12)
20 patients
Age (years)
48.1 ± 13.1 (20–59)
50.3 ± 10.1 (34–65)
51.1 ± 16.2 (20–80)
.861
BMI (kg/m2)
32 ± 6.7 (22–42)
28.5 ± 4.3 (22–36)
29.6 ± 4.9 (21–39)
.117
ASA Score
1 (1–2)
1 (1–2)
2 (1–2)
.441
Pre-Op eGFR (ml/min/1.73m2)
86.1 ± 20.9 (55–141)
76.9 ± 18.6 (43–126)
91 ± 30 (40–140)
.183
Pre-Op Hb (gm/dl)
14.1 ± 1.05 (13–15.9)
13.2 ± 1.8 (10.5–16.4)
12.6 ± 1.7 (9.1–15.5)
.064
Sex: male/female
7 (63.6%)/4 (36.4%)
13 (65%)/7 (35%)
9/(45%)/11 (55%)
.388
Side: right/left
8 (72.7%)/3 (27.3%)
12 (60%)/8 (40%)
10 (50%)/10 (50%)
.465
CKD (ml/min/1.73m2)
   
.104
 > 90
4/11 (36.4%)
3/20 (15%)
10/20 (50%)
 60–89
6/11 (54.5%)
14/20 (70%)
6/20 (30%)
 30–59
1/11 (9.1%)
3/20 (15%)
4/20 (20%)
Clinical T
   
.095
 T1
10/11 (90.9%)
15/20 (75%)
11/20 (55%)
 T2
1/11 (9.1%)
5/20 (25%)
9/20 (45%)
OR time (h)
2.6 ± 0.57 (1.7–3.5)
3.1 ± 0.78 (2–5)
3.03 ± 0.65 (2–4.5)
.174
WIT (min)
14 (0–20)
15 (0–30)
19 (0–40)
.343
LOS (days)
4 (3–9)
5 (4–29)
5 (4–11)
.109
Hb loss (gm/dl)
1 (0.4–3.5)
1 (0.2–3.7)
1 (0.1–5.3)
.788
Blood loss (ml)
150 (50–1500)
300 (100–900)
300 (50–1100)
.272
Ischemia type
   
.251
 Warm ischemia
7/11 (63.6%)
18/20 (90%)
15/20 (75%)
 No ischemia
4/11 (36.4%)
2/20 (10%)
5/20 (25%)
Hilar position
0/11
3/20 (5.9%)
7/20 (13.7%)
.053
RPS
    
 Intrarenal/extrarenal
7 (63.6%)/4 (36.4%)
14 (70%)/6 (30%)
14 (70%)/6 (30%)
.922
PCS entry
5/11 (45.5%)
8/20 (40%)
13/20 (65%)
.263
Post-Op Hb (gm/dl)
12.6 ± 1.5 (10 - 14.3)
11.9 ± 1.6 (9 - 15.8)
11.3 ± 2 (7.1–15)
.148
Total complications
2/11 (18.2%)
9/20 (52.9%)
6/20 (30%)
.292
Secondary intervention
2/11 (18.2%)
7/20 (35%)
1/20 (5%)
.039*
VC
1/11 (9.1%)
2/20 (10%)
1/20 (5%)
1
Ureteric injury
0/11
2/20 (10%)
0/20
.341
Blood transfusion
2/11 (18.2%)
3/20 (15%)
4/20 (20%)
1
Leakage
0/11
5/20 (25%)
1/20 (5%)
.124
Drain removal (d)
4 (3–8)
4.5 (3–28)
5 (4–7)
.243
Conversion to RN
1/11 (9.1%)
1/20 (5%)
2/20 (10%)
1
RF impairment
1/11 (9.1%)
2/20 (10%)
3/20 (11.8%)
1
Positive margin
0/11
1/20 (5%)
2/20 (10%)
.789
Post-Op eGFR 3mo (ml/min/1.73m2)
78.6 ± 17.5 (60–114.3)
74.8 ± 19.3 (32–117)
80.1 ± 27 (21.8–130)
.750
Values are presented as mean ± SD (range), Median (range) or number of patients (%) as appropriate
AML angiomyolipoma, ASA American society of anesthesiology, BMI body mass index, CKD chronic kidney disease, eGFR estimated glomerular filtration rate, Hb hemoglobin, LOS length of hospital stay, OR operative, PCS pelvi-calyceal system, Post-Op postoperative, Pre-Op preoperative, RF renal function, RN radical nephrectomy, RPS renal pelvic score, VC vascular complications, WIT warm ischemia time
*Significant
Table 4
Renal mass complexity according to newly modified score in relation to outcome parameters
 
Complexity according to MNS
p
Low (5–9)
15 patient
Moderate (10–14)
20 patient
High (15–23)
16 patient
Age (years)
49.3 ± 12.3 (20–63)
51.9 ± 13.7 (30–80)
48.8 ± 13.9 (20–65)
.941
BMI (kg/m2)
31.4 ± 6.2 (22–42)
27.3 ± 4.1 (21–36)
31.4 ± 4.5 (25–39)
.022*
ASA Score
1 (1–2)
1 (1–2)
2 (1–2)
.404
Pre-Op eGFR (ml/min/1.73m2)
84.9 ± 18.7 (55–141)
81.7 ± 25.3 (43–130)
87.3 ± 29.1 (40–140)
.788
Pre-Op Hb (gm/dl)
14 ± 1.3 (11.4–16.4)
12.7 ± 1.9 (9.1–15.8)
13 ± 1.5 (10.1–15.6)
.091
Sex: male/female
8 (53.3%)/7 (46.7%)
11 (55%)/9 (45%)
10 (56.9%)/6 (37.5%)
.856
Side: right/left
11 (73.3%)/4 (26.7%)
8 (40%)/12 (60%)
11 (68.8%)/5 (31.3%)
.087
CKD (ml/min/1.73m2)
   
.583
  > 90
5/15 (33.3%)
5/20 (25%)
7/16 (43.8%)
 60–89
9/15 (60%)
11/20 (55%)
6/16 (37.5%)
 30–59
1/15 (6.7%)
4/20 (20%)
3/16 (18.8%)
Clinical T
   
.216
 T1
13/15 (86.7%)
14/20 (70%)
9/16 (56.2%)
 T2
2/15 (13.3%)
6/20 (30%)
7/16 (43.8%)
OR time (h)
2.7 ± 0.67 (1.7–4.25)
3 ± 0.79 (2–5)
3.1 ± 0.57 (2.25–4)
.153
WIT (min)
14 (0–20)
18.5 (0–40)
16.5 (0–27)
.070
LOS (day)
4 (3–9)
5 (4–29)
5 (4–14)
.077
Hb loss (gm/dl)
1 (0.2–3.5)
1 (0.10–3.7)
1 (0.1–5.3)
.937
Blood loss (ml)
150 (50–1500)
275 (50–900)
475 (50–1100)
.081
Ischemia type
   
.317
 Warm ischemia
11/15 (73.3%)
18/20 (90%)
11/16 (68.8%)
 No ischemia
4/15 (26.7%)
2/20 (10%)
5/16 (31.2%)
Hilar position
0/10
0/10
10/10 (100%)
<.001*
RPS
   
.049*
 Intrarenal/extrarenal
7 (46.7%)/8 (53.3%)
14 (70%)/6 (30%)
14 (87.5%)/2 (12.5%)
PCS entry
5/15 (33.3%)
11/20 (55%)
10/16 (62.5%)
.241
Post-Op Hb (gm/dl)
12.7 ± 1.5 (10–15.8)
11.4 ± 1.8 (7.1–14.5)
11.5 ± 1.7 (8.6–15)
.074
Total complications
2/15 (13.3%)
6/20 (30%)
9/16 (56.3%)
.037*
Secondary intervention
2/15 (13.3%)
5/20 (25%)
3/16 (18.8%)
.757
VC
1/15 (6.7%)
2/20 (10%)
1/16 (6.3%)
1
Ureteric injury
0/15
1/20 (5%)
1/16 (6.3%)
1
Blood Transfusion
2/15 (13.3%)
2/20 (10%)
5/16 (31.3%)
.269
Leakage
0/15
4/20 (20%)
2/16 (12.5%)
.255
Drain removal (d)
4 (3–8)
4.5 (4–28)
5 (3–14)
.200
Conversion to RN
1/15 (6.7%)
1/20 (5%)
2/16 (12.5%)
.818
RF impairment
1/15 (6.7%)
2/20 (10%)
3/16 (18.8%)
.647
Positive margin
0/15
0/20
3/16 (18.8%)
.049*
Post-Op eGFR 3mo (ml/min/1.73m2)
79.6 ± 15.4 (60–114)
78.3 ± 23.1 (27–117)
75.3 ± 26.7 (21.8–130)
.856
Values are presented as mean ± SD (range), Median (range) or number of patients (%) as appropriate
AML angiomyolipoma, ASA American society of anesthesiology, BMI body mass index, CKD chronic kidney disease, eGFR estimated glomerular filtration rate, Hb hemoglobin, LOS length of hospital stay, MNS newly modified nephrometry score, OR operative, PCS pelvi-calyceal system, Post-Op postoperative, Pre-Op preoperative, RF renal function, RN radical nephrectomy, RPS renal pelvic score, VC vascular complications, WIT warm ischemia time
*Significant

3.4 Predicting factors for postoperative complications

This was confirmed by analysis of predicting factors for postoperative complications (Table 5). The detected significant predicting factors were the complexity level according to MNS (p = 0.037), MNS (p = 0.014) and hilar position (p = 0.001).
Table 5
Predicting factors for postoperative complications
 
Patient without complications
34 patient
Patient with complications
17 patient
p
Age (years)
50.4 ± 14.76 (20–80)
49.6 ± 9.9 (30–65)
.815
BMI (kg/m2)
29.1 ± 5 (21–40)
31.3 ± 5.6 (25–42)
.151
ASA Score
1 (1–2)
2 (1–2)
.327
Pre-Op eGFR (ml/min/1.73m2)
86.6 ± 26.2 (43–141)
80 ± 20.9 (40–130)
.372
Pre-Op Hb (gm/dl)
13.3 ± 1.8 (9.1–16.4)
12.9 ± 1.5 (10.8–15.8)
.399
Sex
  
.842
 Male
19/29 (65.5%)
10/29 (34.5%)
 Female
15/22 (68.2%)
7/22 (31.8%)
Side
  
.07
 Right
23/30 (76.7%)
7/30 (23.3%)
 Left
11/21 (52.4%)
10/21 (47.6%)
Solitary kidney
1/2 (50%)
1/2 (50%)
1
CKD (ml/min/1.73m2)
  
.381
 > 90
13/17 (76.5%)
4/17 (23.5%)
 60–89
15/26 (57.7%)
11/26 (42.3%)
 30–59
6/8 (75%)
2/8 (25%)
cT
  
.192
 T1
26/36 (72.2%)
10/36 (27.8%)
 T2
8/15 (53.3%)
7/15 (46.7%)
RPS
  
.393
 Intrarenal
22/35 (62.9%)
13/35 (37.1%)
 Extrarenal
12/16 (75%)
4/16 (25%)
R
  
.122
 1
10/11 (90.9%)
1/11 (9.1%)
 2
17/27 (63%)
10/27 (37%)
 3
7/13 (53.8%)
6/13 (46.2%)
E
  
.421
 1
10/15 (66.7%)
5/15 (33.3%)
 2
19/26 (73.1%)
7/26 (26.9%)
 3
5/10 (50%)
5/10 (50%)
N
  
.755
 1
10/15 (66.7%)
5/15 (33.3%)
 2
9/12 (75%)
3/12 (25%)
 3
15/24 (62.5%)
9/24 (37.5%)
L
  
.387
 1
7/8 (87.5%)
1/8 (12.5%)
 2
11/17 (64.7%)
6/17 (35.3%)
 3
16/26 (61.5%)
10/26 (38.5%)
Hilar position
2/10 (20%)
8/10 (80%)
.001*
Complexity
  
.292
 Low
9/11 (81.8%)
2/11 (18.2%)
 Moderate
11/20 (55%)
9/20 (45%)
 High
14/20 (70%)
6/20 (30%)
Modified complexity
  
.037*
 Low
13/15 (86.7%)
2/15 (13.3%)
 Moderate
14/20 (70%)
6/20 (30%)
 High
7/16 (43.8%)
9/16 (56.2%)
R.E.N.A.L.
8 (4–12)
9 (6–11)
.151
MNS
11 (6–19)
15 (7–22)
.014*
Values are presented as mean ± SD (range), median (range) or number of patients (%) as appropriate
ASA American society of anesthesiology, BMI body mass index, CKD chronic kidney disease, eGFR estimated glomerular filtration rate, Hb hemoglobin, MNS newly modified nephrometry score, Pre-Op preoperative, RPS renal pelvic score
*Significant

4 Discussion

R.E.N.A.L. is one of the nephrometry scoring systems that proved its reproducibility and minimal inter-observer variability [21, 22]. It was used to predict the outcome of PN based on the complexity of renal mass in multiple studies; most of them were retrospective. In our prospective study, we aimed at evaluating the ability of R.E.N.A.L., and our MNS in prediction of the risk of perioperative complications, conversion to RN and other outcome variables. We had 17 (33%) patients with perioperative complications. This was in the range of reported complications in other studies (24.24–38.46%) [2, 13, 2326]. We had 4 cases (7.8%) of conversion to RN which was similar to that found in different studies (6–16.3%) [17, 27, 28].
Similar to our study, many studies showed no significant difference in the rate of complications [1317, 27], estimated amount of blood loss [1518, 27] transfusion rate [13, 14, 18, 27], ischemia time [1316], length of hospital stay [13, 15, 16, 18, 27], operative time [1316, 18, 23, 27], positive surgical margins, [27] and change in eGFR [14, 16, 18, 27], in relation to R.E.N.A.L. and different complexity grades. On the other hand, other studies reported significant difference in the rate of some outcome parameters according to R.E.N.A.L. including the rate of total complications [18, 23], ischemia time [14, 15, 17, 18, 23, 27], the total operative time [17], estimated blood loss [1423], length of hospital stay [1423], renal function impairment [15] and the possibility of conversion to RN [17, 27].
As there was no statistically significant difference in nearly all of the outcome parameters according to different complexity levels using R.E.N.A.L., we tried to modify R.E.N.A.L. hoping that it will better predict the postoperative outcome and complications. We incorporated both the hilar position and RPS. Additionally, a significant limitation to the original R.E.N.A.L was giving an equal strength to its different components although some items may affect the complexity of the surgery more than others. Consequently, we modified the scoring of some items with giving more strength to E and N. These modifications were supported by what reported in the previous literature. Tomaszewski and colleagues evaluated the renal pelvic anatomy as an independent predictor of urine leak in 255 patients undergoing open PN. Despite the presence of more lesions with higher R.E.N.A.L. scores in patients with an extrarenal pelvis, the presence of an intrarenal pelvis was highly independently associated with risk of urine leak and rate of secondary intervention [20]. This was confirmed in other studies [29]. In the study reported by Liu et al. [18], only nearness to the collecting system “N”, out of the five components of R.E.N.A.L., was significantly associated with both incidence of complications and postoperative hemorrhage. Furthermore, Bruner et al. [30] reported that “E” score out of other components of R.E.N.A.L. was a significant predictor of postoperative urine leak. Tomaszewski et al. [29] reported that “E” score had a strong independent association with urine leak while the overall NS and its other components were not associated with urine leak.
The application of these modifications was associated with marked improvement in the ability of the complexity level to predict different outcome parameters. This was confirmed by analysis of different predicting factors for occurrence of complications which revealed MNS, complexity level according to MNS and hilar position as the only significant predictors. However, original R.E.N.A.L or its individual components (R, E, N, L) were found to be non-significant.
Our study has some limitations. The most important one is the relatively small sample size. Another limiting factor was the use of warm ischemia in some patients and zero ischemia in others. Moreover, we did not evaluate the split renal function. Furthermore, we had different pathologies including benign lesions. However, our newly modified score was associated with better prediction of the outcome of PN including complications even in the presence of a small sample size. The comparison of MNS versus R.E.N.A.L. added to the strength of the study. The prospective evaluation is another strong point. The short period of recruitment of patients with use of the same surgical technique by the same surgeon helped to abolish their effects on outcome. These finding will be better confirmed in a larger studies using the same ischemia protocol. Additionally, a longer follow-up may help to detect the effect of positive surgical margin on the rate of recurrence free survival.

5 Conclusions

The newly modified nephrometry score was associated with better prediction of the outcome of PN when compared to R.E.N.A.L. nephrometry score. Thus, it can be used for better prediction of the outcome following partial nephrectomy.

Acknowledgements

Not applicable.
All procedures performed were in accordance with the ethical standards of the institutional and national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. The study was approved by the Cairo University - Faculty of Medicine - Research Ethics Committee on 12/03/2014. [Committee’s reference number 12032014]. A written Informed consent was obtained from all patients included in the study.
Not applicable.

Competing interests

Prof Ashraf Mosharafa, Editor-in-Chief of the journal confirms that he was not involved in the editorial processing or peer review process for this manuscript. The authors declare that they have no conflict of interest.
Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://​creativecommons.​org/​licenses/​by/​4.​0/​.

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Unsere Produktempfehlungen

e.Med Interdisziplinär

Kombi-Abonnement

Für Ihren Erfolg in Klinik und Praxis - Die beste Hilfe in Ihrem Arbeitsalltag

Mit e.Med Interdisziplinär erhalten Sie Zugang zu allen CME-Fortbildungen und Fachzeitschriften auf SpringerMedizin.de.

e.Med Urologie

Kombi-Abonnement

Mit e.Med Urologie erhalten Sie Zugang zu den urologischen CME-Fortbildungen und Premium-Inhalten der urologischen Fachzeitschriften.

Literatur
1.
Zurück zum Zitat Hollingsworth JM, Miller DC, Daignault S et al (2006) Rising incidence of small renal masses: a need to reassess treatment effect. J Natl Cancer Inst 98(18):1331–1334CrossRef Hollingsworth JM, Miller DC, Daignault S et al (2006) Rising incidence of small renal masses: a need to reassess treatment effect. J Natl Cancer Inst 98(18):1331–1334CrossRef
2.
Zurück zum Zitat Mir MC, Derweesh I, Porpiglia F et al (2017) Partial nephrectomy versus radical nephrectomy for clinical T1b and T2 renal tumors: a systematic review and meta-analysis of comparative studies. Eur Urol 71(4):606–617 (Review)CrossRef Mir MC, Derweesh I, Porpiglia F et al (2017) Partial nephrectomy versus radical nephrectomy for clinical T1b and T2 renal tumors: a systematic review and meta-analysis of comparative studies. Eur Urol 71(4):606–617 (Review)CrossRef
3.
Zurück zum Zitat McKiernan J, Simmons R, Katz J et al (2002) Natural history of chronic renal insufficiency after partial and radical nephrectomy. Urology 59(6):816–820CrossRef McKiernan J, Simmons R, Katz J et al (2002) Natural history of chronic renal insufficiency after partial and radical nephrectomy. Urology 59(6):816–820CrossRef
4.
Zurück zum Zitat Uzzo RG, Novick AC (2001) Nephron sparing surgery for renal tumors: indications, techniques and outcomes. J Urol 166(1):6–18CrossRef Uzzo RG, Novick AC (2001) Nephron sparing surgery for renal tumors: indications, techniques and outcomes. J Urol 166(1):6–18CrossRef
5.
Zurück zum Zitat Kunkle DA, Egleston BL, Uzzo RG (2008) Excise, ablate or observe: the small renal mass dilemma–a meta-analysis and review. J Urol 179(4):1227–1234CrossRef Kunkle DA, Egleston BL, Uzzo RG (2008) Excise, ablate or observe: the small renal mass dilemma–a meta-analysis and review. J Urol 179(4):1227–1234CrossRef
7.
Zurück zum Zitat Long CJ, Canter DJ, Kutikov A et al (2012) Partial nephrectomy for renal masses ≥ 7 cm: technical, oncological and functional outcomes. BJU Int 109(10):1450–1456CrossRef Long CJ, Canter DJ, Kutikov A et al (2012) Partial nephrectomy for renal masses ≥ 7 cm: technical, oncological and functional outcomes. BJU Int 109(10):1450–1456CrossRef
8.
Zurück zum Zitat Lee HJ, Liss MA, Derweesh IH (2014) Outcomes of partial nephrectomy for clinical T1b and T2 renal tumors. Curr Opin Urol 24(5):448–452CrossRef Lee HJ, Liss MA, Derweesh IH (2014) Outcomes of partial nephrectomy for clinical T1b and T2 renal tumors. Curr Opin Urol 24(5):448–452CrossRef
9.
Zurück zum Zitat Van Poppel H, Da Pozzo L, Albrecht W et al (2007) A prospective randomized EORTC intergroup phase 3 study comparing the complications of elective nephron-sparing surgery and radical nephrectomy for low-stage renal cell carcinoma. Eur Urol 51(6):1606–1615CrossRef Van Poppel H, Da Pozzo L, Albrecht W et al (2007) A prospective randomized EORTC intergroup phase 3 study comparing the complications of elective nephron-sparing surgery and radical nephrectomy for low-stage renal cell carcinoma. Eur Urol 51(6):1606–1615CrossRef
10.
Zurück zum Zitat Ficarra V, Novara G, Secco S et al (2009) Preoperative aspects and dimensions used for an anatomical (PADUA) classification of renal tumours in patients who are candidates for Nephron-Sparing Surgery. Eur Urol 56(5):786–793CrossRef Ficarra V, Novara G, Secco S et al (2009) Preoperative aspects and dimensions used for an anatomical (PADUA) classification of renal tumours in patients who are candidates for Nephron-Sparing Surgery. Eur Urol 56(5):786–793CrossRef
11.
Zurück zum Zitat Simmons MN, Ching CB, Samplaski MK et al (2010) Kidney tumor location measurement using the C index method. J Urol 183(5):1708–1713CrossRef Simmons MN, Ching CB, Samplaski MK et al (2010) Kidney tumor location measurement using the C index method. J Urol 183(5):1708–1713CrossRef
12.
Zurück zum Zitat Kutikov A, Uzzo RG (2009) The R.E.N.A.L. nephrometry score: a comprehensive standardized system for quantitating renal tumor size, location and depth. J Urol 182(3):844–853CrossRef Kutikov A, Uzzo RG (2009) The R.E.N.A.L. nephrometry score: a comprehensive standardized system for quantitating renal tumor size, location and depth. J Urol 182(3):844–853CrossRef
13.
Zurück zum Zitat Roushiasa S, Vasdeva N, Ganai B et al (2013) Can the R.E.N.A.L nephrometry score preoperatively predict postoperative clinical outcomes in patients undergoing open and laparoscopic partial nephrectomy? Curr Urol 7(2):90–97CrossRef Roushiasa S, Vasdeva N, Ganai B et al (2013) Can the R.E.N.A.L nephrometry score preoperatively predict postoperative clinical outcomes in patients undergoing open and laparoscopic partial nephrectomy? Curr Urol 7(2):90–97CrossRef
14.
Zurück zum Zitat Hayn MH, Schwaab T, Underwood W et al (2011) RENAL nephrometry score predicts surgical outcomes of laparoscopic partial nephrectomy. BJU Int 108(6):876–881PubMed Hayn MH, Schwaab T, Underwood W et al (2011) RENAL nephrometry score predicts surgical outcomes of laparoscopic partial nephrectomy. BJU Int 108(6):876–881PubMed
15.
Zurück zum Zitat Okhunov Z, Rais-Bahrami S, George AK et al (2011) The comparison of three renal tumor scoring systems: C-Index, P.A.D.U.A., and R.E.N.A.L. nephrometry scores. J Endourol 25(12):1921–1924CrossRef Okhunov Z, Rais-Bahrami S, George AK et al (2011) The comparison of three renal tumor scoring systems: C-Index, P.A.D.U.A., and R.E.N.A.L. nephrometry scores. J Endourol 25(12):1921–1924CrossRef
16.
Zurück zum Zitat Mufarrij PW, Krane LS, Rajamahanty S et al (2011) Does nephrometry scoring of renal tumors predict outcomes in patients selected for robot-assisted partial nephrectomy? J Endourol 25(10):1649–1653CrossRef Mufarrij PW, Krane LS, Rajamahanty S et al (2011) Does nephrometry scoring of renal tumors predict outcomes in patients selected for robot-assisted partial nephrectomy? J Endourol 25(10):1649–1653CrossRef
17.
Zurück zum Zitat Matos AC, Dall’Oglio MF, Colombo JR Jr et al (2017) Predicting outcomes in partial nephrectomy: Is the renal score useful? Int Braz J Urol 43(3):422–431CrossRef Matos AC, Dall’Oglio MF, Colombo JR Jr et al (2017) Predicting outcomes in partial nephrectomy: Is the renal score useful? Int Braz J Urol 43(3):422–431CrossRef
18.
Zurück zum Zitat Liu ZW, Olweny EO, Yin G et al (2013) Prediction of perioperative outcomes following minimally invasive partial nephrectomy: role of the R.E.N.A.L nephrometry score. World J Urol 31(5):1183–1189CrossRef Liu ZW, Olweny EO, Yin G et al (2013) Prediction of perioperative outcomes following minimally invasive partial nephrectomy: role of the R.E.N.A.L nephrometry score. World J Urol 31(5):1183–1189CrossRef
19.
Zurück zum Zitat Levey AS, Greene T, Kusek J et al (2000) A simplified equation to predict glomerular filtration rate from serum creatinine [abstract A0828]. J Am Soc Nephrol 11:155A Levey AS, Greene T, Kusek J et al (2000) A simplified equation to predict glomerular filtration rate from serum creatinine [abstract A0828]. J Am Soc Nephrol 11:155A
20.
Zurück zum Zitat Tomaszewski JJ, Cung B, Smaldone MC et al (2014) Renal pelvic anatomy is associated with incidence, grade, and need for intervention for urine leak following partial nephrectomy. Eur Urol 66(5):949–955CrossRef Tomaszewski JJ, Cung B, Smaldone MC et al (2014) Renal pelvic anatomy is associated with incidence, grade, and need for intervention for urine leak following partial nephrectomy. Eur Urol 66(5):949–955CrossRef
21.
Zurück zum Zitat Montag S, Waingankar N, Sadek MA et al (2011) Reproducibility and fidelity of the R.E.N.A.L. nephrometry score. J Endourol 25(12):1925–1928CrossRef Montag S, Waingankar N, Sadek MA et al (2011) Reproducibility and fidelity of the R.E.N.A.L. nephrometry score. J Endourol 25(12):1925–1928CrossRef
22.
Zurück zum Zitat Weight CJ, Atwell TD, Fazzio RT et al (2011) A multidisciplinary evaluation of inter-reviewer agreement of the nephrometry score and the prediction of long-term outcomes. J Urol 186(4):1223–1228CrossRef Weight CJ, Atwell TD, Fazzio RT et al (2011) A multidisciplinary evaluation of inter-reviewer agreement of the nephrometry score and the prediction of long-term outcomes. J Urol 186(4):1223–1228CrossRef
23.
Zurück zum Zitat Simhan J, Smaldone MC, Tsai KJ et al (2011) Objective measures of renal mass anatomic complexity predict rates of major complications following partial nephrectomy. Eur Urol 60(4):724–730CrossRef Simhan J, Smaldone MC, Tsai KJ et al (2011) Objective measures of renal mass anatomic complexity predict rates of major complications following partial nephrectomy. Eur Urol 60(4):724–730CrossRef
24.
Zurück zum Zitat Deklaj T, Lifshitz DA, Shikanov SA et al (2010) Laparoscopic radical versus laparoscopic partial nephrectomy for clinical T1bN0M0 renal tumors: comparison of perioperative, pathological, and functional outcomes. J Endourol 24(10):1603–1607CrossRef Deklaj T, Lifshitz DA, Shikanov SA et al (2010) Laparoscopic radical versus laparoscopic partial nephrectomy for clinical T1bN0M0 renal tumors: comparison of perioperative, pathological, and functional outcomes. J Endourol 24(10):1603–1607CrossRef
25.
Zurück zum Zitat Roos FC, Brenner W, Thomas C et al (2012) Functional analysis of elective nephron-sparing surgery vs radical nephrectomy for renal tumors larger than 4 cm. Urology 79(3):607–613CrossRef Roos FC, Brenner W, Thomas C et al (2012) Functional analysis of elective nephron-sparing surgery vs radical nephrectomy for renal tumors larger than 4 cm. Urology 79(3):607–613CrossRef
26.
Zurück zum Zitat Brewer K, O’Malley RL, Hayn M et al (2012) Perioperative and renal function outcomes of minimally invasive partial nephrectomy for T1b and T2a kidney tumors. J Endourol 26(3):244–248CrossRef Brewer K, O’Malley RL, Hayn M et al (2012) Perioperative and renal function outcomes of minimally invasive partial nephrectomy for T1b and T2a kidney tumors. J Endourol 26(3):244–248CrossRef
27.
Zurück zum Zitat Long JA, Arnoux V, Fiard G et al (2013) External validation of the RENAL nephrometry score in renal tumours treated by partial nephrectomy. BJU Int 111(2):233–239CrossRef Long JA, Arnoux V, Fiard G et al (2013) External validation of the RENAL nephrometry score in renal tumours treated by partial nephrectomy. BJU Int 111(2):233–239CrossRef
28.
Zurück zum Zitat Galvin DJ, Savage CJ, Adamy A et al (2011) Intraoperative conversion from partial to radical nephrectomy at a single institution from 2003 to 2008. J Urol 185(4):1204–1209CrossRef Galvin DJ, Savage CJ, Adamy A et al (2011) Intraoperative conversion from partial to radical nephrectomy at a single institution from 2003 to 2008. J Urol 185(4):1204–1209CrossRef
29.
Zurück zum Zitat Tomaszewski JJ, Smaldone MC, Cung B et al (2014) Internal validation of the renal pelvic score: a novel marker of renal pelvic anatomy that predicts urine leak after partial nephrectomy. Urology 84(2):351–357CrossRef Tomaszewski JJ, Smaldone MC, Cung B et al (2014) Internal validation of the renal pelvic score: a novel marker of renal pelvic anatomy that predicts urine leak after partial nephrectomy. Urology 84(2):351–357CrossRef
30.
Zurück zum Zitat Bruner B, Breau RH, Lohse CM et al (2011) Renal nephrometry score is associated with urine leak after partial nephrectomy. BJU Int 108(1):67–72CrossRef Bruner B, Breau RH, Lohse CM et al (2011) Renal nephrometry score is associated with urine leak after partial nephrectomy. BJU Int 108(1):67–72CrossRef
Metadaten
Titel
Modified R.E.N.A.L nephrometry score for predicting the outcome following partial nephrectomy
verfasst von
Mohammed Salah
Mohammed S. ElSheemy
Waleed Ghoneima
Mahmoud Abd El Hamid
Ayman Kassem
Ahmed Abdallah Ashmawy
Ismail R. Saad
Ashraf A. Mosharafa
Hosni Khairy Salem
Hesham Badawy
Ahmed Salem
Publikationsdatum
01.12.2020
Verlag
Springer Berlin Heidelberg
Erschienen in
African Journal of Urology / Ausgabe 1/2020
Print ISSN: 1110-5704
Elektronische ISSN: 1961-9987
DOI
https://doi.org/10.1186/s12301-020-00056-3

Weitere Artikel der Ausgabe 1/2020

African Journal of Urology 1/2020 Zur Ausgabe

Ambulantisierung: Erste Erfahrungen mit dem Hybrid-DRG

02.05.2024 DCK 2024 Kongressbericht

Die Hybrid-DRG-Verordnung soll dazu führen, dass mehr chirurgische Eingriffe ambulant durchgeführt werden, wie es in anderen Ländern schon länger üblich ist. Die gleiche Vergütung im ambulanten und stationären Sektor hatten Niedergelassene schon lange gefordert. Aber die Umsetzung bereitet ihnen doch Kopfzerbrechen.

Sind Frauen die fähigeren Ärzte?

30.04.2024 Gendermedizin Nachrichten

Patienten, die von Ärztinnen behandelt werden, dürfen offenbar auf bessere Therapieergebnisse hoffen als Patienten von Ärzten. Besonders gilt das offenbar für weibliche Kranke, wie eine Studie zeigt.

Harninkontinenz: Netz-Op. erfordert über lange Zeit intensive Nachsorge

30.04.2024 Harninkontinenz Nachrichten

Frauen mit Belastungsinkontinenz oder Organprolaps sind nach einer Netz-Operation keineswegs beschwerdefrei. Vielmehr scheint die Krankheitslast weiterhin hoch zu sein, sogar höher als von harninkontinenten Frauen, die sich nicht haben operieren lassen.

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Update Urologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.